Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The breast cancer (BC) disease burden in working-age men was investigated between 1990 and 2021.
Methods: Age-standardized incidence rates (ASIRs), prevalence rates ASPRs), and death rates (ASDRs), as well as age-standardized disability-adjusted life years rate (DALYs) on global, regional, and national levels between 1990 and 2021, were determined to assess the BC disease burden in working-age men (aged 15-64 years), together with risk factor and health inequality analyses.
Results: Globally, the ASIR, ASPR, ASDR, and age-standardized DALY rate in 2021 were 0.77 per 100,000 males (0.46‒0.99), 6.34 per 100,000 males (3.97‒8.02), 0.22 per 100,000 males (0.14‒0.28), and 8.75 per 100,000 males (5.58‒11.40), respectively. The burden of disease varied among regions and countries. Risk factor analysis revealed a marked influence of diets high in red meat on the ASDR and age-standardized DALY rate. Cross-national social inequality analysis identified marked inequalities, both relative and absolute, in the disease burden among regions, with higher burdens found in countries with lower sociodemographic indices.
Conclusions: The BC disease burden has escalated in men of working age, accompanied by a decline in life expectancy since the 1990s and increases in associated deaths and DALYs. Low-income regions exhibited a more substantial burden compared to high-income regions. The key to reducing the disease burden lies in enhancing national economic strength, with improvements in medical systems and the development of targeted clinical guidelines.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clbc.2025.07.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A new frontier in oncology: Understanding the landscape of cancer vaccines.
J Oncol Pharm Pract
September 2025
Department of Research & Development, Squad Medicine and Research (SMR), Amadalavalasa, Andhra Pradesh, India.
Cancer vaccines represent a transformative shift in oncology, aiming to prevent malignancies or treat established cancers by training the immune system to recognize tumor-specific or tumor-associated antigens. This review explores the diverse platforms and mechanisms supporting cancer vaccines, ranging from prophylactic vaccines such as HPV and hepatitis B vaccines that have significantly reduced virus-related cancers to therapeutic vaccines like Sipuleucel-T and T-VEC that extend survival in prostate cancer and melanoma. Vaccine types are classified, and delivery platforms including mRNA, peptide, dendritic cell and viral vector-based approaches are examined alongside pivotal clinical trial outcomes.
View Article and Find Full Text PDFMicrobial cell-free DNA for diagnosis of bacterial and fungal infection in the immunocompromised host - what do we know?
Curr Opin Infect Dis
August 2025
Transplant and Immunocompromised Host Infectious Diseases, Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital.
Purpose Of Review: Plasma metagenomic next-generation sequencing (mNGS) enables detection of microbial cell-free deoxyribonucleic acid (mcfDNA) in blood without the need for culture or organism-specific primers. Here, we review clinical performance, methodological variability, and real-world application of plasma mNGS for infectious disease diagnosis in immunocompromised hosts (ICHs).
Recent Findings: Plasma mNGS has rapidly gained attention as a novel diagnostic tool for infections in ICHs, offering broad-range pathogen detection from a noninvasive blood sample.
Exploring healthcare professionals' perceptions on implementing home hemodialysis and self-assisted hemodialysis: a qualitative explorative study.
Int Urol Nephrol
September 2025
Division of Nursing, Singapore General Hospital, Singapore, Singapore.
Objective: To explore healthcare professionals' perceptions on the implementation of home hemodialysis and self-assisted hemodialysis in Singapore and to identify the perceived barriers, facilitators, and actionable strategies for increasing uptake.
Methods: This is a qualitative explorative study based on semi-structured face-to-face interviews conducted with a multidisciplinary group of 12 healthcare professionals at an acute teaching hospital in Singapore. Thematic analysis was used for data analysis.
G20 stroke burden 1990-2035: trends, projections and precision health insights.
Neurol Sci
September 2025
School of Public Health, Shaanxi University of Chinese Medicine, Shaanxi, 712046, Xianyang, P. R. China.
Background: Stroke persists as the second leading global cause of mortality and disability. We analyzed G20 nations using Global Burden of Disease (GBD) 2021 data (1990-2021) to provide a new perspective.
Methods: We obtained age-standardized rates (ASR) of stroke mortality, incidence, prevalence, and YLLs (years of life lost) across G20 nations.
Immediate perioperative safety and resource utilization of stand-alone middle meningeal artery embolization and stand-alone surgical evacuation for chronic subdural hematoma.
Interv Neuroradiol
September 2025
Department of Neurosurgery, Albany Medical Center, Albany, NY, USA.
ObjectiveRandomized trials will ultimately determine whether stand-alone middle meningeal artery embolization (MMAE) is effective in preventing the recurrence of chronic subdural hematoma (cSDH). We therefore characterized in-hospital complications, length of stay, and discharge disposition among adults undergoing stand-alone MMAE for non-traumatic cSDH in the United States.MethodsWe conducted a retrospective cohort analysis using the National Inpatient Sample (2016-2022) to identify adult patients (≥18 years) with a primary diagnosis of nontraumatic cSDH.
View Article and Find Full Text PDF